Bristol-Myers Squibb Company
DE ˙ XTRA ˙ US1101221083
47,43 € ↓ -0,01 (-0,01%)
2026-06-04
DEL PRIS
SecurityDE:BRM / Bristol-Myers Squibb Company
InstitutionGolden State Equity Partners
Latest Disclosed Ownership2,105 shares
Latest Disclosed Value $ 127,767
Golden State Equity Partners ownership in BRM / Bristol-Myers Squibb Company

On April 28, 2026 - Golden State Equity Partners filed a 13F-HR form disclosing ownership of 2,105 shares of Bristol-Myers Squibb Company (DE:BRM) valued at $110,344 USD as of March 31, 2026. The entity filed a previous 13F-HR on January 24, 2025 disclosing 0 shares of Bristol-Myers Squibb Company. The current value of the position is $99,840 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2026-04-28 2026-03-31 13F BRISTOL MYERS SQUIBB COMMON STOCK 110122108 2,105 2,105 128 0.0029
2025-01-24 2024-12-31 13F BRISTOL-MYERS SQUIBB COM 110122108 0 -290 -100.00 0 -100.00
2025-01-24 2024-12-31 13F BRISTOL-MYERS SQUIBB COM 110122108 0 -290 0
2024-10-29 2024-09-30 13F/A-1 BRISTOL-MYERS SQUIBB COM 110122108 290 290 15 0.0079
2024-02-02 2023-12-31 13F BRISTOL-MYERS SQUIBB COM 110122108 0 -13,188 -100.00 0 -100.00
2023-10-20 2023-09-30 13F BRISTOL-MYERS SQUIBB COM 110122108 13,188 10,839 461.43 765 410.00 0.2133
2023-07-19 2023-06-30 13F BRISTOL-MYERS SQUIBB COM 110122108 2,349 -5,249 -69.08 150 -71.48 0.0422
2023-06-01 2023-03-31 13F BRISTOL-MYERS SQUIBB COM 110122108 7,598 -12,013 -61.26 527 -63.27 0.2850
2022-05-18 2022-03-31 13F/A-1 BRISTOL-MYERS SQUIBB COM 110122108 19,611 12,900 192.22 1,432 242.58 0.7207
2022-05-16 2022-03-31 13F BRISTOL-MYERS SQUIBB COM 110122108 15,339 8,628 968 0.5525
2022-02-11 2021-12-31 13F BRISTOL-MYERS SQUIBB COM 110122108 6,711 408 6.47 418 12.06 0.2111
2021-11-15 2021-09-30 13F BRISTOL-MYERS SQUIBB COM 110122108 6,303 -11,640 -64.87 373 -68.89 0.1520
2021-08-12 2021-06-30 13F BRISTOL-MYERS SQUIBB COM 110122108 17,943 2,604 16.98 1,199 23.86 0.4625
2021-05-13 2021-03-31 13F BRISTOL-MYERS SQUIBB COM 110122108 15,339 15,339 968 0.5525
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.